A vs EW · P/E 29, rev $1.88B vs P/E 47, rev $1.39B
Agilent Technologies Inc (A) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
A currently screens at market cap $33.70B and trailing P/E 29.2. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the A and EW stock pages for the full models.
Not investment advice.